Medical products

Greenrise Global’s medical cannabis subsidiary, AMP Alternative Medical Products GmbH, announces the start of dronabinol sales in Germany

Dronabinol is pure tetrahydrocannabinol (THC) and is registered as an active pharmaceutical ingredient (API) and has been registered for sale with the competent authorities in Germany. Doctors and pharmacists can find more information about the product or order on the AMP website:

AMP and Eurox have entered into a non-exclusive agreement for the marketing and distribution of Dronabinol for sale in pharmacies from February 2022. In preparation for the launch of pharmacy sales, AMP trained its national sales team on the benefits of Dronabinol for patients to physicians and preparation methods for pharmacists.

Eurox was one of the first medical cannabis companies to produce Dronabinol made in Germany to one of Europe largest GMP facilities located in Hesse, Germany and controls the entire supply chain, from cultivation, production to distribution, ensuring a stable and efficient supply to its customers.

Neil Smith, the President of Eurox commented: “If you believe in ‘Made in Germany‘, it means Eurox. AMP’s focus on serving German patients and its national sales coverage make it an ideal partner for us.”

dr. Stefan Feuerstein, President and Director of Greenrise Global and Managing Director of AMP, “The German market is gravitating towards pharmaceuticals as health authorities tighten their regulatory oversight to ensure patient safety. Dronabinol is a well-established product in the Germany, and we expect it to be one of our best-selling products this year.”

About Eurox Pharma

Eurox Pharma is one of Europe leading medical cannabis companies. Eurox is vertically integrated, with:

  • Fully owned German subsidiaries responsible for product development and intellectual property.
  • Manufactured to EU GMP in Germany with a German pharmaceutical partner.
  • A cultivation facility at Portugal ensure vertical integration and independence of supply.
  • A significant minority stake in Integro Medical Clinics, a UK-registered medical cannabis clinic.
  • Various high caliber distribution partnerships in Germany and other European countries and its own sales team.

For more information on Eurox, please visit

About Greenrise Global Brands

Greenrise Global helps people realize the beneficial properties of cannabis. Greenrise Global is a publicly traded Canadian company with two German operating subsidiaries: Greenrise GmbH (“Greenrise Wellbeing”) and AMP Alternative Medical Products GmbH (“AMP”). Greenrise Wellbeing is a CBD wellness company based in Hamburg, with brands such as Herbify and CANAVEX® in his wallet.

AMP is based in Erfurt and supplies medical cannabis products to pharmacies across Germany, including the medical cannabis brands of Aphria, Bedrocan, Small green pharmacy and GPAof the branded product line and sold through its national sales team. AMP complies with the German Narcotics Act (BtMG) and the regulatory requirements of the Free State of Thuringia, ensuring that products imported from around the world and sold in Germany Meet the European Union Good Manufacturing Practice (EU-GMP) standard.

For more information about Greenrise Global, please visit



Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This press release contains forward-looking statements based on the Company’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to its business plans and milestones and their calendar. Although the Company believes that the expectations expressed in these forward-looking statements are based on reasonable assumptions, these statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Accordingly, actual results may differ materially from those expressed in such forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless the otherwise required by law.

SOURCE Greenrise Global Brands Inc.

For further information: GREENRISE CONTACT: Hendrik Knopp, Director, [email protected], +1 236-833-1602; Media inquiries: Valeria Bravo, Corporate Communications and Media, [email protected], +1 604-689-7533; AMP CONTACT: Dr. Stefan Feuerstein, President, Greenrise Global Inc., Managing Director, AMP Alternative Medical Products GmbH, [email protected], +49 151 7284 4643; EUROX CONTACT: Jessica Smith, International Director of Public Relations and Marketing, [email protected]

Tags : medical productssupply chain
Joan J. Dean

The author Joan J. Dean